Lion Point Capital, LP’s Janux Therapeutics Inc Position
Does Lion Point Capital, LP own Janux Therapeutics Inc (JANX)? Yes — 19.0K shares worth $264,100 (+1.58% of its 13F portfolio) as of Q1 2026.
Position Value
$264,100
Q1 2026
Shares
19.0K
% of Portfolio
+1.58%
Quarters Held
2
currently held
Position History JANX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of JANX.